- Home
- ACON
ACON
Aclarion Inc.
as 07-26-2024 4:00pm EST
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | BROOMFIELD |
| Market Cap: | 2.6M | IPO Year: | 2022 |
| Target Price: | N/A | AVG Volume (30 days): | 347.7K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -7.02 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.27 - $11.50 | Next Earning Date: | 08-23-2024 |
| Revenue: | $60,048 | Revenue Growth: | -21.90% |
| Revenue Growth (this year): | -16.13% | Revenue Growth (next year): | 222.58% |
Latest Aclarion Inc. News
ACON Breaking Stock News: Dive into ACON Ticker-Specific Updates for Smart Investing
GlobeNewswire
18 days ago
Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK
GlobeNewswire
a month ago
Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK
GlobeNewswire
a month ago
Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London
NewMediaWire
a month ago
Aclarion Receives Notice of Allowance for US Patent to Support Further Optimization of Accuracy and Reliability in the Nociscan Solution
NewMediaWire
a month ago
Aclarion Announces Updated Product Release That Enhances User-Experience, Scalability, and Security for Nociscan Solution
ACCESSWIRE
3 months ago
Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
NewMediaWire
3 months ago
Aclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain
NewMediaWire
3 months ago
Aclarion to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
Compare ACON vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ACON Aclarion Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.